Compare Piramal Healthcare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ALKEM LABORATORIES - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ALKEM LABORATORIES PIRAMAL ENTERPRISES/
ALKEM LABORATORIES
 
P/E (TTM) x -30.6 - - View Chart
P/BV x 1.1 9.2 11.5% View Chart
Dividend Yield % 2.2 0.5 465.6%  

Financials

 PIRAMAL ENTERPRISES   ALKEM LABORATORIES
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ALKEM LABORATORIES
Mar-16
PIRAMAL ENTERPRISES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,3031,589 207.8%   
Low Rs1,7971,232 145.8%   
Sales per share (Unadj.) Rs716.5417.5 171.6%  
Earnings per share (Unadj.) Rs79.756.3 141.6%  
Cash flow per share (Unadj.) Rs107.964.7 166.8%  
Dividends per share (Unadj.) Rs28.0012.70 220.5%  
Dividend yield (eoy) %1.10.9 122.0%  
Book value per share (Unadj.) Rs1,477.5292.9 504.4%  
Shares outstanding (eoy) m184.45119.57 154.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.63.4 105.3%   
Avg P/E ratio x32.025.1 127.7%  
P/CF ratio (eoy) x23.621.8 108.4%  
Price / Book Value ratio x1.74.8 35.8%  
Dividend payout %35.122.6 155.7%   
Avg Mkt Cap Rs m470,292168,653 278.9%   
No. of employees `0007.8NA-   
Total wages/salary Rs m22,5049,171 245.4%   
Avg. sales/employee Rs Th16,899.4NM-  
Avg. wages/employee Rs Th2,877.7NM-  
Avg. net profit/employee Rs Th1,879.9NM-  
INCOME DATA
Net Sales Rs m132,15349,915 264.8%  
Other income Rs m3,1281,645 190.1%   
Total revenues Rs m135,28151,561 262.4%   
Gross profit Rs m66,2908,482 781.5%  
Depreciation Rs m5,2021,006 517.2%   
Interest Rs m44,097671 6,575.8%   
Profit before tax Rs m20,1198,451 238.1%   
Minority Interest Rs m3,194-114 -2,806.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6111,606 536.2%   
Profit after tax Rs m14,7016,731 218.4%  
Gross profit margin %50.217.0 295.2%  
Effective tax rate %42.819.0 225.2%   
Net profit margin %11.113.5 82.5%  
BALANCE SHEET DATA
Current assets Rs m122,74227,062 453.6%   
Current liabilities Rs m310,81015,324 2,028.3%   
Net working cap to sales %-142.323.5 -605.2%  
Current ratio x0.41.8 22.4%  
Inventory Days Days2367 34.7%  
Debtors Days Days3941 94.1%  
Net fixed assets Rs m116,90412,610 927.1%   
Share capital Rs m369239 154.3%   
"Free" reserves Rs m272,16134,490 789.1%   
Net worth Rs m272,53035,027 778.1%   
Long term debt Rs m270,1961,212 22,300.8%   
Total assets Rs m856,26154,387 1,574.4%  
Interest coverage x1.513.6 10.7%   
Debt to equity ratio x1.00 2,866.2%  
Sales to assets ratio x0.20.9 16.8%   
Return on assets %6.913.6 50.5%  
Return on equity %5.419.2 28.1%  
Return on capital %12.424.9 50.0%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m15,2006,563 231.6%   
Fx outflow Rs m4,8893,012 162.3%   
Net fx Rs m10,3123,552 290.3%   
CASH FLOW
From Operations Rs m-115,9757,259 -1,597.8%  
From Investments Rs m-8,2651,864 -443.4%  
From Financial Activity Rs m107,525-9,273 -1,159.6%  
Net Cashflow Rs m-16,650-150 11,100.1%  

Share Holding

Indian Promoters % 52.9 66.9 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 33.1 12.1%  
FIIs % 26.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 0.0 -  
Shareholders   93,274 68,381 136.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  JUBILANT LIFE SCIENCES  AJANTA PHARMA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Crashed 600 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended their session deep in the red.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

My View on ITC(Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now(Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

PSU Banks Will Move Up Again(Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

Why India's Drone Revolution is a 4x Profit Opportunity(Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 28, 2020 03:36 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS